Kolexia
D'Oiron Roseline
Biologie médicale
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
158 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Hémophilie B Thrombasthénie Maladies de von Willebrand Troubles de l'hémostase et de la coagulation Troubles de l'hémostase Hémarthrose Ménorragie

Industries

Sobi
19 collaboration(s)
Dernière en 2023
Roche
12 collaboration(s)
Dernière en 2021
Takeda Pharmaceutical
11 collaboration(s)
Dernière en 2023
KEPHREN PUBLISHING
8 collaboration(s)
Dernière en 2023

Dernières activités

PRESent-2: A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
Essai Clinique (ApcinteX Ltd)   15 mars 2024
HAVEN 6: A Multicenter, Open-Label Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Emicizumab in Patients With Mild or Moderate Hemophilia A Without FVIII Inhibitors
Essai Clinique (Roche)   08 mars 2024
PRESent-3: A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Hemophilia B With Inhibitors
Essai Clinique (ApcinteX Ltd)   04 mars 2024
explorer7: Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B With Inhibitors
Essai Clinique (Novo Nordisk)   26 février 2024
Acquired haemophilia A in paediatric patients: A retrospective French cohort of eight cases.
British journal of haematology   08 janvier 2024
PHILEOS: Haemophilia and Bone Loss PHILEOS Study
Essai Clinique (CHU Saint-Étienne)   29 décembre 2023
PedNet: The European Paediatric Network for Haemophilia Management and the PedNet Haemophilia Registry
Essai Clinique (PedNet Haemophilia Research Foundation)   26 octobre 2023
Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis.
Research and practice in thrombosis and haemostasis   21 octobre 2023
The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status.
Haematologica   01 octobre 2023
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.
The New England journal of medicine   11 septembre 2023